Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI

Conclusion: A greater DepOR is significantly associated with PFS benefit in advanced NSCLC treated with EGFR-TKI, suggesting that it may be a useful clinical outcome to evaluate the response of targeted therapy.

Source: Journal of Cancer - December 14, 2019 Category: Cancer & Oncology Authors: Yu-Tao Liu, Kai Zhang, Cheng-Cheng Li, Xing-Sheng Hu, Jun Jiang, Xue-Zhi Hao, Yan Wang, Jun-Ling Li, Pu-Yuan Xing, Sheng Yang, Xin Zhang, Guo-Qiang Wang, Shang-Li Cai, Yuan-Kai Shi Tags: Research Paper Source Type: research